Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rockville, MD
SEC filing record 1 source field available
Fiscal year end
31 December
NovaBridge Biosciences has filed 324 SEC EDGAR filings since 29 Jul 2019

SEC filing history

Showing 301-324 of 324 matching filings.

Per page
25
Current page
13
424B4 File 333-234363

424(B)(4)

Filing date
21 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-234363

EFFECT filing

Filing date
16 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-235557

EFFECT filing

Filing date
16 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
15 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-39173

8A CERT

Filing date
14 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1/A File 333-234363

AMENDMENT NO.3 TO FORM F-1

Filing date
14 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-39173

FORM 8-A12B

Filing date
03 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1/A File 333-234363

AMENDMENT NO.2 TO FORM F-1

Filing date
03 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-6 File 333-235557

F-6 filing

Filing date
18 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1/A File 333-234363

AMENDMENT NO.1 TO FORM F-1

Filing date
04 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1 File 333-234363

FORM F-1

Filing date
29 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
04 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-02758

DRS/A filing

Filing date
04 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
12 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
05 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-02758

DRS/A filing

Filing date
05 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
29 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-02758

DRS filing

Filing date
29 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .